1. Ajima, R, Ikematsu, N, Ohsugi, M, Yoshida, Y, Yamamoto, T. . Cloning and characterization of the mouse tob2 gene. In Gene, 253, 215-20. doi:. https://pubmed.ncbi.nlm.nih.gov/10940559/
2. Bao, Nan, Zhang, Pengjie, Zhu, Yanting, Wu, Bing, Ding, Tong. 2022. miR-378a-3p promotes renal cell carcinoma proliferation, migration, and invasion by targeting TOB2. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 25, 748-757. doi:10.1007/s12094-022-02984-8. https://pubmed.ncbi.nlm.nih.gov/36309620/
3. Lee, Seung Min, Yoon, Bo Hyun, Lee, Jin Woo, Kim, Young-Hak, Ha, Chang Hoon. 2024. Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. In Microvascular research, 155, 104698. doi:10.1016/j.mvr.2024.104698. https://pubmed.ncbi.nlm.nih.gov/38801943/
4. Ikematsu, N, Yoshida, Y, Kawamura-Tsuzuku, J, Fujimoto, J, Yamamoto, T. . Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. In Oncogene, 18, 7432-41. doi:. https://pubmed.ncbi.nlm.nih.gov/10602502/
5. Takahashi, Akinori, Morita, Masahiro, Yokoyama, Kazumasa, Suzuki, Toru, Yamamoto, Tadashi. 2012. Tob2 inhibits peroxisome proliferator-activated receptor γ2 expression by sequestering Smads and C/EBPα during adipocyte differentiation. In Molecular and cellular biology, 32, 5067-77. doi:10.1128/MCB.00610-12. https://pubmed.ncbi.nlm.nih.gov/23071089/
6. Shen, Hongxing, Li, Wenjuan, Tian, Yuan, Zhang, Jinxiang, Li, Youjun. . Upregulation of miR-362-3p Modulates Proliferation and Anchorage-Independent Growth by Directly Targeting Tob2 in Hepatocellular Carcinoma. In Journal of cellular biochemistry, 116, 1563-73. doi:10.1002/jcb.25110. https://pubmed.ncbi.nlm.nih.gov/25649327/
智鼠故事 
